<h3>Gainers</h3>
<ul>
<li>VivoSim Labs (NASDAQ:VIVS) shares moved upwards by 62.0% to $2.75 during Friday's regular session. The company's market cap stands at $4.4 million. </li>
<li>cbdMD (AMEX:YCBD) shares increased by 51.1% to $1.17. The company's market cap stands at $8.0 million. </li>
<li>Adlai Nortye (NASDAQ:ANL) stock increased by 29.82% to $8.48. The market value of their outstanding shares is at $240.9 million. </li>
<li>Aspire Biopharma Hldgs (NASDAQ:ASBP) shares increased by 28.75% to $1.88. The company's market cap stands at $5.8 million. </li>
<li>Aprea Therapeutics (NASDAQ:APRE) stock rose 23.84% to $0.73. The market value of their outstanding shares is at $4.1 million. </li>
<li>Venus Concept (NASDAQ:VERO) shares increased by 22.31% to $1.48. The company's market cap stands at $2.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quince Therapeutics (NASDAQ:QNCX) shares fell 26.7% to $0.2 during Friday's regular session. The company's market cap stands at $15.0 million. </li>
<li>Dermata Therapeutics (NASDAQ:DRMA) shares decreased by 21.82% to $2.2. The market value of their outstanding shares is at $7.9 million. </li>
<li>Basel Medical Group (NASDAQ:BMGL) stock decreased by 19.84% to $0.72. The market value of their outstanding shares is at $16.8 million. </li>
<li>Lexicon Pharmaceuticals (NASDAQ:LXRX) stock decreased by 19.8% to $1.16. The market value of their outstanding shares is at $523.2 million. </li>
<li>Fractyl Health (NASDAQ:GUTS) shares decreased by 19.64% to $0.47. The company's market cap stands at $89.7 million. </li>
<li>Nuwellis (NASDAQ:NUWE) stock decreased by 19.1% to $3.39. The company's market cap stands at $3.7 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In Friday's trading session, several health care stocks experienced significant movements. Notable gainers included VivoSim Labs (up 62.0% to $2.75), cbdMD (up 51.1% to $1.17), and Adlai Nortye (up 29.82% to $8.48). Conversely, Quince Therapeutics saw a decline of 26.7% to $0.20, while Dermata Therapeutics fell 21.82% to $2.20. Other losers included Basel Medical Group and Lexicon Pharmaceuticals, which dropped 19.84% and 19.8%, respectively. The market caps of these companies varied widely, reflecting their differing valuations.

benzinga_article

Dermata Therapeutics

SPDR S&P Health Equip

VG Health

DERMATA THERAPEUTICS INC C/WTS (TO PUR COM)

Lexicon Pharma

ALPS Medical Breakthrough

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Basel Medical

Adlai Nortye

iShares US Medical Devices

VivoSim Labs

Invesco Nasdaq Biotechnology ETF

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

SPDR S&P Health

Quince Therapeutics

iShares US Healthcare Providers

Health Care Select Sector SPDR

cbdMD

iShares Biotechnology ETF

iShares US Pharma

12 Health Care Stocks Moving In Friday's Intraday Session